Streetbeat News

Analyst Ratings

PTON

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Peloton Interactive (NASDAQ:PTON) and lowered the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:54 pm

QLYS

Wedbush analyst Daniel Ives maintains an Outperform rating on Qualys (NASDAQ:QLYS) and raises the price target from $160 to $170.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:53 pm

MRNA

Goldman Sachs analyst Salveen Richter maintains a Buy rating on Moderna (NASDAQ:MRNA) but lowers the price target from $269 to $231.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:51 pm

KBR

Goldman Sachs analyst Jerry Revich maintains a Buy rating on KBR (NYSE:KBR) but lowers the price target from $75 to $66.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:48 pm

KRTX

Goldman Sachs analyst Corinne Jenkins has maintained a 'Buy' rating on Karuna Therapeutics (NASDAQ:KRTX), but lowered the price target from $332 to $296.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:47 pm

PYPL

A significant bearish stance has been taken on PayPal Holdings (NASDAQ:PYPL) by a large investor, as indicated by unusual options trading activity. The sentiment among these big-money traders is 21% bullish and 78% bearish. The whales have been targeting a price range from $55.0 to $77.5 for PayPal over the last 3 months. Analysts from Morgan Stanley, Truist Securities, RBC Capital, HSBC, and Oppenheimer have maintained their positive ratings on PayPal, with price targets ranging from $65 to $118.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 2:46 pm

JD

A significant bearish stance has been taken on JD.com (NASDAQ:JD) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 15% bullish and 84% bearish. The whales have been targeting a price range from $20.0 to $35.0 for JD.com over the last 3 months. The current price of JD.com is up 3.18% at $26.63. Several financial institutions have maintained their Buy rating on JD.com with varying price targets.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 2:45 pm

IONS

Goldman Sachs analyst Salveen Richter maintains a 'Sell' rating on Ionis Pharmaceuticals (NASDAQ:IONS) but raises the price target from $25 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:44 pm

IDXX

Goldman Sachs analyst Nathan Rich has maintained a 'Buy' rating on IDEXX Laboratories (NASDAQ:IDXX), but lowered the price target from $578 to $500.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:42 pm

AAPL

Wedbush analyst Daniel Ives has reiterated an Outperform rating on Apple (NASDAQ:AAPL) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:41 pm